Environmental Impact Acquisition Corp Cl A (ENVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ENVI | TRVI | CRBU | ||
Company | Environmental Impact Acquisition Corp Cl A | Trevi Therapeutics Inc | Caribou Biosciences Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 8.73 | 3.23 | 2.50 | ||
High | 9.50 | 3.39 | 2.58 | ||
Low | 8.61 | 3.12 | 2.44 | ||
Last | 8.82 | 3.25 | 2.49 | ||
Change | +0.25 | +0.08 | +0.05 | ||
% Change | +2.92% | +2.52% | +2.05% | ||
Volume | 19,200 | 149,500 | 1,143,800 | ||
20-Day Average Volume | 182,410 | 333,095 | 2,353,795 | ||
Previous Close | 8.57 | 3.17 | 2.44 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 9.72 | 2.83 | 2.05 | ||
20-Day Raw Stochastic | 16.13% | 85.58% | 79.52% | ||
20-Day Relative Strength | 28.64% | 62.94% | 54.34% | ||
Weighted Alpha | -14.20 | +18.92 | -61.56 | ||
Today's Opinion | 64% Sell | 72% Buy | 56% Sell | ||
Previous Opinion | 56% Sell | 72% Buy | 56% Sell | ||
Last Month's Opinion | 88% Buy | 16% Buy | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -11.71% since 01/26/22 | +16.91% since 07/19/24 | +8.50% since 07/19/24 | ||
Low | 8.57 on 02/01/22 | 2.71 on 07/22/24 | 2.18 on 07/22/24 | ||
High | 10.12 on 02/01/22 | 3.39 on 07/26/24 | 2.58 on 07/26/24 | ||
1-Month | |||||
%Chg | -11.09% since 12/31/21 | +22.64% since 06/26/24 | +53.70% since 06/26/24 | ||
Low | 8.57 on 02/01/22 | 2.42 on 07/05/24 | 1.50 on 07/09/24 | ||
High | 10.12 on 02/01/22 | 3.39 on 07/26/24 | 2.74 on 07/16/24 | ||
3-Month | |||||
%Chg | -11.45% since 11/02/21 | +16.91% since 04/26/24 | -32.88% since 04/26/24 | ||
Low | 8.57 on 02/01/22 | 2.30 on 06/10/24 | 1.50 on 07/09/24 | ||
High | 10.12 on 02/01/22 | 3.39 on 07/26/24 | 3.93 on 05/06/24 | ||
6-Month | |||||
%Chg | -8.98% since 08/02/21 | +108.33% since 01/26/24 | -54.40% since 01/26/24 | ||
Low | 8.57 on 02/01/22 | 1.35 on 02/02/24 | 1.50 on 07/09/24 | ||
High | 10.12 on 02/01/22 | 4.00 on 03/21/24 | 8.33 on 02/28/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 228,218 | 228,914 | 224,892 | ||
Shares Outstanding, K | 25,875 | 70,435 | 90,318 | ||
Annual Sales | 0 | 0 | 34,480,000 | ||
Annual Net Income | 0 | -29,070,000 | -102,070,000 | ||
Last Quarter Sales | 0 | 0 | 2,430,000 | ||
Last Quarter Net Income | -1,526,562 | -10,900,000 | -41,230,000 | ||
60-Month Beta | N/A | 1.00 | 2.29 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.11 on 05/07/24 | -0.46 on 05/07/24 | ||
Latest Earnings Date | 12/07/15 | 08/08/24 | 08/13/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |